lexcorpRevenue for the infusion system is estimated to be $4Mp.a...

lexcorp

Revenue for the infusion system is estimated to be $4Mp.a in Brazil and up to $8Mp.a in Taiwan (after ramp up periods).

As an example of per hospital revenues, the Concord Hospital sales contract was estimated at $500k but retooling and developing the device to be a full infusion system delayed sales - the infusion system being the autostart fitted with the autoflush feature

The devices sell in hospitals for anywhere from $6 - $12+ each. I believe ALT gets between $1-2 royalty per unit. Can start to see the potential volumes if you factor in a new burette everyday per patient per bed who is hooked up to a pump.

Burette market is estimated to be $3Bn p.a but largely dominated by a few major multinationals - hence why they are securing the area less dominated (Taiwan & Brazil) first. Kind of like monopoly.